Schonfeld Strategic Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-11,000
| Closed | -$44.9K | – | 2435 |
|
|
2023
Q1 | $44.9K | Sell |
11,000
-19,900
| -64% | -$81.2K | ﹤0.01% | 1721 |
|
|
2022
Q4 | $155K | Sell |
30,900
-41,482
| -57% | -$208K | ﹤0.01% | 2034 |
|
|
2022
Q3 | $946K | Buy |
+72,382
| New | +$946K | 0.01% | 1290 |
|
|
2022
Q1 | – | Sell |
-13,700
| Closed | -$243K | – | 2828 |
|
|
2021
Q4 | $243K | Buy |
+13,700
| New | +$243K | ﹤0.01% | 1569 |
|
|
2021
Q3 | – | Sell |
-30,253
| Closed | -$597K | – | 2407 |
|
|
2021
Q2 | $597K | Buy |
+30,253
| New | +$597K | 0.01% | 1071 |
|
|
2019
Q3 | – | Sell |
-55,000
| Closed | -$805K | – | 1282 |
|
|
2019
Q2 | $805K | Buy |
+55,000
| New | +$805K | 0.03% | 505 |
|